WO2012131618A1 - Composition comprenant des cellules souches mésenchymateuses dérivées de la gelée de wharton et procédés associés - Google Patents

Composition comprenant des cellules souches mésenchymateuses dérivées de la gelée de wharton et procédés associés Download PDF

Info

Publication number
WO2012131618A1
WO2012131618A1 PCT/IB2012/051519 IB2012051519W WO2012131618A1 WO 2012131618 A1 WO2012131618 A1 WO 2012131618A1 IB 2012051519 W IB2012051519 W IB 2012051519W WO 2012131618 A1 WO2012131618 A1 WO 2012131618A1
Authority
WO
WIPO (PCT)
Prior art keywords
serum
composition
combination
cord
cells
Prior art date
Application number
PCT/IB2012/051519
Other languages
English (en)
Inventor
Malancha TA
Anish Sen MAJUMDAR
Original Assignee
Stempeutics Research Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stempeutics Research Private Limited filed Critical Stempeutics Research Private Limited
Publication of WO2012131618A1 publication Critical patent/WO2012131618A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des procédés d'isolement, de culture et de mise en commun de cellules dérivées de la gelée de Wharton pour obtenir une composition de cellules souches allogéniques mésenchymateuses mises en commun (MSC). Le procédé comprend la collecte de cordons ombilicaux de donneurs multiples suivie par l'isolement, la culture et la mise en commun des WJ-MSC à partir desquelles la composition thérapeutique finale est formulée. La composition ainsi obtenue réduit la variabilité biologique. Puisque la présente composition est aussi immunomodulatrice de nature, elle peut être utilisée pour la gestion des troubles à médiation immune et une immunosuppression supplémentaire peut être requise quand on utilise cette composition pour la gestion des troubles à médiation immune.
PCT/IB2012/051519 2011-03-30 2012-03-29 Composition comprenant des cellules souches mésenchymateuses dérivées de la gelée de wharton et procédés associés WO2012131618A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1004CH2011 2011-03-30
IN1004/CHE/2011 2011-03-30

Publications (1)

Publication Number Publication Date
WO2012131618A1 true WO2012131618A1 (fr) 2012-10-04

Family

ID=46929580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/051519 WO2012131618A1 (fr) 2011-03-30 2012-03-29 Composition comprenant des cellules souches mésenchymateuses dérivées de la gelée de wharton et procédés associés

Country Status (1)

Country Link
WO (1) WO2012131618A1 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014075589A1 (fr) * 2012-11-14 2014-05-22 贾在美 Injection de cellules souches mésenchymateuses, procédé de préparation associé, et application associée dans la préparation d'un médicament contre le diabète
WO2015058318A1 (fr) 2013-10-22 2015-04-30 Universidad De Chile Composition permettant d'accélérer ou d'améliorer la cicatrisation de plaies et méthode permettant d'accélérer ou d'améliorer la cicatrisation de plaies qui comprend l'application de ladite composition
WO2015145370A1 (fr) * 2014-03-26 2015-10-01 Stempeutics Research Pvt. Ltd. Prise en charge des ischémies au moyen d'une composition de cellules stromales mésenchymateuses regroupées
US9441201B2 (en) 2010-06-01 2016-09-13 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
WO2016193836A1 (fr) * 2015-06-01 2016-12-08 Stempeutics Research Private Limited Procédé de préparation de cellules stromales mésenchymateuses pour une indication spécifique et composition correspondante
WO2017026838A1 (fr) * 2015-08-12 2017-02-16 주식회사 차바이오텍 Cellules souches adhésives améliorées dérivées de cordon ombilical, leur procédé de préparation, et leur utilisation
EP3140417A4 (fr) * 2014-05-09 2018-05-23 Reelabs Private Limited Polymix foetal de cellules souches mésenchymateuses placé dans des conditions hypoxiques en vue du traitement d'affections cliniques
EP3149157A4 (fr) * 2014-05-24 2018-06-13 Neelamkrishnan Venkataramanaa Procédé pour cibler un glioblastome avec des cellules souches mésenchymateuses de la gelée de wharton (cms-gw) dérivées de cordon ombilical humain
CN108660108A (zh) * 2017-03-31 2018-10-16 四川新生命干细胞科技股份有限公司 一种可增强脐带间充质干细胞免疫调节能力的方法
CN109315386A (zh) * 2018-12-12 2019-02-12 中南大学湘雅三医院 一种可用于造血干细胞或淋巴细胞的冻存液及冻存方法
KR20190017006A (ko) * 2015-08-12 2019-02-19 (주)차바이오텍 향상된 탯줄 유래 부착형 줄기세포, 그의 제조방법 및 용도
WO2019158712A1 (fr) * 2018-02-16 2019-08-22 Nextcell Pharma Ab Composition allogénique
US10542743B2 (en) 2015-01-05 2020-01-28 Hygieia Therapeutics Sdn Bhd Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells
WO2020150308A1 (fr) * 2019-01-16 2020-07-23 University Of Utah Research Foundation Feuilles de cellules souches mésenchymateuses de cordon ombilical humain et procédés pour leur production
WO2021028583A1 (fr) 2019-08-15 2021-02-18 Nextcell Pharma Ab Composition allogénique pour le traitement de troubles du système nerveux central

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011101834A1 (fr) * 2010-02-22 2011-08-25 Advanced Neuro-Science Allies Private Limited Procédé d'obtention de cellules souches mésenchymateuses, milieux utilisés, procédés et composition associés

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011101834A1 (fr) * 2010-02-22 2011-08-25 Advanced Neuro-Science Allies Private Limited Procédé d'obtention de cellules souches mésenchymateuses, milieux utilisés, procédés et composition associés

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CAVALLO, C. ET AL., COMPARISON OF ALTERNATIVE MESENCHYMAL STEM CELL SOURCES FOR CELL BANKING AND MUSCULOSKELETAL ADVANCED THERAPIES, vol. 112, no. 5, May 2011 (2011-05-01), pages 1418 - 1430 *
FONG, C.-Y. ET AL.: "'Derivation efficiency, cell proliferation, freeze-thaw survival, stem- cell properties and differentiation of human Wharton's jelly stem cells'.", REPRODUCTIVE BIOMEDICINE, vol. 21, no. 3, September 2010 (2010-09-01), pages 391 - 401 *
HUNT, CJ., CRYOPRESERVATION OF HUMAN STEM CELLS FOR CLINICAL APPLICATION: A REVIEW, vol. 38, no. 2, April 2011 (2011-04-01), pages 107 - 123 *
LIANG, J. ET AL.: "Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis", MULTIPLE SCLEROSIS., vol. 15, no. 5, May 2009 (2009-05-01), pages 644 - 646 *
NEKANTI, U. ET AL.: "'Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells'.", STEM CELLS AND DEVELOPMENT., vol. 19, no. 1, January 2010 (2010-01-01), pages 117 - 130 *
NEKANTI, U. ET AL.: "'Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications'.", STEM CELL RESEARCH., vol. 5, no. 3, November 2010 (2010-11-01), pages 244 - 254, XP027408720 *
PETSA, A. ET AL.: "'Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications'.", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL., vol. 45, no. 10, December 2009 (2009-12-01), pages 573 - 576 *
SUN, L. ET AL.: "Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus", ARTHIRITIS & RHEUMATISM., vol. 62, no. 8, August 2010 (2010-08-01), pages 2467 - 2475 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9441201B2 (en) 2010-06-01 2016-09-13 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
US9920301B2 (en) 2010-06-01 2018-03-20 Auxocell Laboratories, Inc. Native Wharton's jelly stem cells and their purification
WO2014075589A1 (fr) * 2012-11-14 2014-05-22 贾在美 Injection de cellules souches mésenchymateuses, procédé de préparation associé, et application associée dans la préparation d'un médicament contre le diabète
WO2015058318A1 (fr) 2013-10-22 2015-04-30 Universidad De Chile Composition permettant d'accélérer ou d'améliorer la cicatrisation de plaies et méthode permettant d'accélérer ou d'améliorer la cicatrisation de plaies qui comprend l'application de ladite composition
WO2015145370A1 (fr) * 2014-03-26 2015-10-01 Stempeutics Research Pvt. Ltd. Prise en charge des ischémies au moyen d'une composition de cellules stromales mésenchymateuses regroupées
US10471101B2 (en) 2014-03-26 2019-11-12 Stempeutics Research Pvt. Ltd. Management of ischemia using pooled mesenchymal stromal cell composition
US11072776B2 (en) 2014-05-09 2021-07-27 Reelabs Private Limited, a Company Incorporated Under Provisions of The Companies Act 1956 Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders and diseases
EP3140417A4 (fr) * 2014-05-09 2018-05-23 Reelabs Private Limited Polymix foetal de cellules souches mésenchymateuses placé dans des conditions hypoxiques en vue du traitement d'affections cliniques
EP3149157A4 (fr) * 2014-05-24 2018-06-13 Neelamkrishnan Venkataramanaa Procédé pour cibler un glioblastome avec des cellules souches mésenchymateuses de la gelée de wharton (cms-gw) dérivées de cordon ombilical humain
US10542743B2 (en) 2015-01-05 2020-01-28 Hygieia Therapeutics Sdn Bhd Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells
WO2016193836A1 (fr) * 2015-06-01 2016-12-08 Stempeutics Research Private Limited Procédé de préparation de cellules stromales mésenchymateuses pour une indication spécifique et composition correspondante
US11690877B2 (en) 2015-08-12 2023-07-04 Cha Biotech Co., Ltd. Umbilical cord-derived adherent stem cells, preparation method therefor, and use thereof
KR20190017006A (ko) * 2015-08-12 2019-02-19 (주)차바이오텍 향상된 탯줄 유래 부착형 줄기세포, 그의 제조방법 및 용도
WO2017026838A1 (fr) * 2015-08-12 2017-02-16 주식회사 차바이오텍 Cellules souches adhésives améliorées dérivées de cordon ombilical, leur procédé de préparation, et leur utilisation
KR102414662B1 (ko) * 2015-08-12 2022-07-01 (주)차바이오텍 향상된 탯줄 유래 부착형 줄기세포, 그의 제조방법 및 용도
CN108660108A (zh) * 2017-03-31 2018-10-16 四川新生命干细胞科技股份有限公司 一种可增强脐带间充质干细胞免疫调节能力的方法
WO2019158712A1 (fr) * 2018-02-16 2019-08-22 Nextcell Pharma Ab Composition allogénique
JP2021514946A (ja) * 2018-02-16 2021-06-17 ネクストセル ファーマ エービー 同種組成物
CN111712565A (zh) * 2018-02-16 2020-09-25 奈科斯特细胞制药有限公司 同种异体组合物
JP7150357B2 (ja) 2018-02-16 2022-10-11 ネクストセル ファーマ エービー 同種組成物
EP4130252A1 (fr) * 2018-02-16 2023-02-08 NextCell Pharma AB Composition allogénique de cellules souches mésenchymales
CN109315386A (zh) * 2018-12-12 2019-02-12 中南大学湘雅三医院 一种可用于造血干细胞或淋巴细胞的冻存液及冻存方法
WO2020150308A1 (fr) * 2019-01-16 2020-07-23 University Of Utah Research Foundation Feuilles de cellules souches mésenchymateuses de cordon ombilical humain et procédés pour leur production
WO2021028583A1 (fr) 2019-08-15 2021-02-18 Nextcell Pharma Ab Composition allogénique pour le traitement de troubles du système nerveux central
WO2022034220A1 (fr) 2019-08-15 2022-02-17 Nextcell Pharma Ab Composition allogénique pour le traitement de troubles de la covid-19

Similar Documents

Publication Publication Date Title
WO2012131618A1 (fr) Composition comprenant des cellules souches mésenchymateuses dérivées de la gelée de wharton et procédés associés
Gomez-Salazar et al. Five decades later, are mesenchymal stem cells still relevant?
Araújo et al. Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord
Mennan et al. Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord
Margossian et al. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion
Bieback et al. Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy
Lovati et al. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells
JP2020055809A (ja) 胎盤幹細胞を使用する免疫調節
Luzzani et al. A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement
Lv et al. Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC
Larsen et al. Potential therapeutic applications of mesenchymal stromal cells
US20150104470A1 (en) Immune modulation by peri-lymphatic or intra-lymphatic cell therapy
JP2018526447A (ja) 細胞拡大培養方法及び治療用組成物
Yew et al. Efficient expansion of mesenchymal stem cells from mouse bone marrow under hypoxic conditions
Widowati et al. Comparative analysis of Wharton’s jelly mesenchymal stem cell (WJ-MSCs) isolated using explant and enzymatic methods
JP2017529068A (ja) 幹細胞組成物および療法適用のための幹細胞を産生する方法
Borzou et al. The effect of age and type of media on growth kinetics of human amniotic fluid stem cells
Ma et al. Immune tolerance of mesenchymal stem cells and induction of skin allograft tolerance
Chen et al. The biological characteristics of sheep umbilical cord mesenchymal stem cells
Anzalone et al. Recent patents and advances on isolation and cellular therapy applications of mesenchymal stem cells from human umbilical cord Wharton's jelly
WO2012070001A1 (fr) Technique de culture d'explant pour l'isolement de cellules souches mésenchymateuses à partir de tissu adipeux
EP3174547A1 (fr) Procédé et appareil pour la récupération de cellules régénératives dérivées de tissu du cordon ombilical et utilisation de celles-ci
RU2645255C1 (ru) Способ получения биобезопасной культуры мезенхимальных стволовых клеток из ворсин хориона человека
JP2013532989A (ja) 羊水由来多能性幹細胞の単離及び自己免疫疾患の処置又は予防におけるその使用
Hui et al. Human serum promotes the proliferation but not the stemness genes expression of human adipose-derived stem cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12765390

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12765390

Country of ref document: EP

Kind code of ref document: A1